Gastrointestinal Endoscopic Devices Market by Product (Hemostatis Devices, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices, Capsule Endoscopes, GI Videoscopes, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Description

Market Overview                      

The global Gastrointestinal Endoscopic Devices market accounted for USD 6.4 Billion in 2020 and is expected to reach USD 11.4 Billion by 2028, growing at a CAGR of around 11% between 2021 and 2028.   

Endoscopy is a procedure that diagnoses, prevents, and treats complications associated with visceral organs. They are used to examine interior hollow organs or cavities in the body. These devices are either placed in the body through natural openings or cavities especially in case of arthroscopy. These devices are equipped with several other parts such as camera or light source which help physicians or medical professionals to analyze internal organs of interest. They are used to investigate symptoms in digestive system, including nausea, vomiting, abdominal pain, difficulty swallowing, and gastrointestinal bleeding.

The partnerships and mergers and acquisitions of players in the Gastrointestinal Endoscopic Devices market is also set to propel the market growth. For example, in June 2017, US Endoscopy, a dominant player across endoscopy equipment design & manufacturing industry launched a new AquaShield® system CO2 – Fujinon, thereby adding to its existing AquaShield water bottle system portfolio. Sources cite that the innovative product is used along with CO2 to provide sterilized water to endoscope while performing of gastrointestinal procedures. The strategic move is anticipated to encourage other industry players to follow the suit, thereby leading to inflation in the growth of gastrointestinal endoscopic devices market.

COVID-19 Impact Analysis:

The lockdowns imposed by various countries to contain the spread of Covid-19 has impacted the global operations and supply chain which had a negative consequences on Gastrointestinal Endoscopic Devices market as the global sales declined. The major reason for decline in market during pandemic outbreak was decrease in patient volume in hospitals, owing to rescheduling and delaying of procedures for safety reasons. Furthermore, delays happened after careful review of patient history and if feasible, healthcare providers rescheduled endoscopic procedures to minimize risk of getting exposed to COVID-19 during hospital visits. All these factors negatively impacted the endoscopy devices market in 2020.

Growth Factors

Shifting lifestyles, lack of physical activities, and growing intake of junk food leading to various gastrointestinal disorders is projected to steer the growth of gastrointestinal endoscopic devices market over the coming years. Apart from this, surge in the number of patients with colon & rectum cancer and increase in the geriatric population base affected as a result of gastrointestinal disorders is anticipated to push the gastrointestinal endoscopic devices market demand.

Fear of hospital acquired infections as a result of endoscopic devices, unfavorable compensation policies, and low government investments in GI devices production, however, is anticipated to hinder the gastrointestinal endoscopic devices market growth in the near future.

Report Scope:  

Segment Analysis Preview  

The main products available in gastrointestinal endoscopic devices market are hemostatis devices, GI Videoscopes, capsule endoscopes, biopsy devices, and retrograde cholangiopancreatography devices. Among them, the demand for GI Videoscopes is relatively higher and the trend is anticipated to remain so over the next few years.

Regional Preview:

Regionally, North America has been leading the worldwide gastrointestinal endoscopic devices market and is anticipated to continue on the dominant position in the years to come, states the market study. For the record, North America contributed over 28% towards global gastrointestinal endoscopic devices market share in 2020.

Key Market Players & Competitive Landscape

The major players operating Gastrointestinal Endoscopic Devices market are Covidien Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Ltd., Olympus Corporation, Fujinon Ltd and Conmed Corporation

The global Gastrointestinal Endoscopic Devices market is segmented as follows:  

By Product

• Hemostatis Devices
• Biopsy Devices
• Endoscopic Retrograde Cholangiopancreatography Devices
• Capsule Endoscopes
• GI Videoscopes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter No. 1: Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2: Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Product
      • 2.1.1.2. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Gastrointestinal Endoscopic Devices Market, 2016 – 2028 (USD Billion)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3: COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4: Gastrointestinal Endoscopic Devices Market – Product Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
  • 4.2. Hemostatis Devices
    • 4.2.1. Market Size and Forecast, By Region (USD Billion)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. Biopsy Devices
    • 4.3.1. Market Size and Forecast, By Region (USD Billion)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Endoscopic Retrograde Chulangiopancreatography Devices
    • 4.4.1. Market Size and Forecast, By Region (USD Billion)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Capsule Endoscopes
    • 4.5.1. Market Size and Forecast, By Region (USD Billion)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. GI Videoscopes
    • 4.6.1. Market Size and Forecast, By Region (USD Billion)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.7. Others
    • 4.7.1. Market Size and Forecast, By Region (USD Billion)
    • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.1. Overview
    • 5.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 5.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
  • 5.2. North America
    • 5.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.2.2. North America Market Revenue, By Product, 2016 – 2028
    • 5.2.5. U.S.
      • 5.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
    • 5.2.6. Canada
      • 5.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
    • 5.2.7. Mexico
      • 5.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
  • 5.3. Europe
    • 5.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.3.2. Europe Market Revenue, By Product, 2016 – 2028
    • 5.3.5. Germany
      • 5.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
    • 5.3.6. France
      • 5.3.6.1. France Market Revenue, By Product, 2016 – 2028
    • 5.3.7. U.K.
      • 5.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
    • 5.3.8. Italy
      • 5.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
    • 5.3.9. Spain
      • 5.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
    • 5.3.10. Rest of Europe
      • 5.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
    • 5.4.5. China
      • 5.4.5.1. China Market Revenue, By Product, 2016 – 2028
    • 5.4.6. Japan
      • 5.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
    • 5.4.7. India
      • 5.4.7.1. India Market Revenue, By Product, 2016 – 2028
    • 5.4.8. South Korea
      • 5.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
    • 5.4.9. South-East Asia
      • 5.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
    • 5.4.10. Rest of Asia Pacific
      • 5.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
  • 5.5. Latin America
    • 5.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.5.2. Latin America Market Revenue, By Product, 2016 – 2028
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
    • 5.5.6. Argentina
      • 5.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
    • 5.5.7. Rest of Latin America
      • 5.5.7.2. Rest of Latin America Market Revenue, By Product, 2016 – 20285
  • 5.6. The Middle-East and Africa
    • 5.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 5.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
    • 5.6.5. GCC Countries
      • 5.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
    • 5.6.6. South Africa
      • 5.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
    • 5.6.7. Rest of Middle-East Africa
      • 5.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
• Chapter No. 6: Gastrointestinal Endoscopic Devices Market – Industry Analysis
  • 6.1. Introduction
  • 6.2. Market Drivers
    • 6.2.1. Driving Factor 1 Analysis
    • 6.2.2. Driving Factor 2 Analysis
  • 6.3. Market Restraints
    • 6.3.1. Restraining Factor Analysis
  • 6.4. Market Opportunities
    • 6.4.1. Market Opportunity Analysis
  • 6.5. Porter’s Five Forces Analysis
  • 6.6. PEST Analysis
  • 6.7. Regulatory Landscape
  • 6.8. Technulogy Landscape
  • 6.9. Regional Market Trends
    • 6.9.1. North America
    • 6.9.2. Europe
    • 6.9.3. Asia Pacific
    • 6.9.4. Latin America
    • 6.9.5. The Middle-East and Africa
  • 6.10. Pricing Analysis
  • 6.11. Value Chain Analysis
  • 6.12. Downstream Buyers
  • 6.13. Distributors/Traders List
• Chapter No. 7: Competitive Landscape
  • 7.1. Company Market Share Analysis – 2019
    • 7.1.1. Global Gastrointestinal Endoscopic Devices Market: Company Market Share, 2019
    • 7.1.2. Global Gastrointestinal Endoscopic Devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
    • 7.1.3. Global Gastrointestinal Endoscopic Devices Market, Company Y-o-Y Growth, 2017 – 2028 (%)
    • 7.1.4. Global Gastrointestinal Endoscopic Devices Market: Radar Determinant Chart, 2019
  • 7.2. Strategic Developments
    • 7.2.1. Acquisitions & Mergers
    • 7.2.2. New Product Launch
    • 7.2.3. Regional Expansion
  • 7.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 8: Company Profiles
  • 8.1. Covidien Ltd
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Product Portfulio
    • 8.1.4. Financial Overview
    • 8.1.5. Operating Business Segments
    • 8.1.6. Business Performance
    • 8.1.7. Recent Developments
  • 8.2. Stryker Corporation
  • 8.3. Boston Scientific Corporation
  • 8.4. Johnson & Johnson Ltd
  • 8.5. Olympus Corporation
  • 8.6. Fujinon Ltd
  • 8.7. Conmed Corporation
• Chapter No. 9: Marketing Strategy Analysis
  • 9.1. Marketing Channel
  • 9.2. Direct Marketing
  • 9.3. Indirect Marketing
  • 9.4. Marketing Channel Development Trends
  • 9.5. Economic/Pulitical Environmental Change
• Chapter No. 10: Research Methodulogy
  • 10.1. Research Methodulogy
  • 10.2. Phase I - Secondary Research
  • 10.3. Phase II - Data Modeling
    • 10.3.1. Company Share Analysis Model
    • 10.3.2. Revenue Based Modeling
  • 10.4. Phase III - Primary Research
  • 10.5. Research Limitations
    • 10.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Gastrointestinal Endoscopic Devices market. Zion Research has collected and analyzed key data belong to the global Gastrointestinal Endoscopic Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Gastrointestinal Endoscopic Devices across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Gastrointestinal Endoscopic Devices industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

• Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
• Helps in validating and strengthening the secondary research findings
• Further, develops the analysis team’s expertise and market understanding
• Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
• Purchasing managers, technical personnel, distributors and resellers
• Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

• Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
• IDC and other relevant magazines
• Internal and external proprietary databases, and relevant patent and regulatory databases
• National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Gastrointestinal Endoscopic Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

• Demographic data: Population split by segments
• Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
• Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
• Data is then cross-checked by an expert panel.

Free Analysis

Endoscopy devices are one of the crucial devices that provide clinical solutions to the demands of the fast-paced world by allowing close examination of internal organs and body structures. As a result of changing lifestyle and increasing consumption of junk food, the gastro intestinal health issues have increased rapidly in last few years. This has led to increasing in the usage of gastrointestinal endoscopy. Gastrointestinal endoscopy devices help the doctor, to have a clear view of inside lining of the patient esophagus and the first part of the patient small intestine.

Upper endoscopy is used to treat conditions of the upper gastrointestinal tract. The scope helps the doctor to have a look if the patient has any ulcer, inflammation, tumors, infection, or bleeding. It helps to collect tissue samples (biopsy), remove polyps, and treat bleeding through the scope. It also helps to find out problems that do not show up on X-ray tests. It is more accurate than X-ray films for detecting inflammation, ulcers, and tumors of the esophagus, stomach, and duodenum.

As a result of changing lifestyle, lack of proper exercise and continuous shift of youngsters towards junk food has given rise to numerous gastrointestinal (GI) disorders which in turn is expected to drive the demand for the gastrointestinal endoscopic devices market during the forecast period. Moreover, increase in a number of patients with colon & rectum cancer, the growing geriatric population with long-term medical conditions such as GI disorders overweight & tobacco consumption are some others factors driving the growth of gastrointestinal endoscopic devices market. However, the fear of infections caused by endoscopes and chances of complications during endoscopy may curb the gastrointestinal endoscopy devices market in the near future. Moreover, lack of government funding and lack of reimbursement policies are some more factors expected to hamper the growth of the global gastrointestinal endoscopic devices market in the near future. Nonetheless, advancements in the gastrointestinal endoscopic devices are expected to open new avenues for the market over the years.

The gastrointestinal endoscopic devices market can be segmented into product segments viz. hemostasis devices, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopes, GI videoscopes, and others (esophageal dilation balloons, stents, polypectomy snares,  and anti-reflux devices).  GI video scores dominated the gastrointestinal endoscopic devices market in 2015 as the result of rising predominance of gastrointestinal disorders such as Crohn's diseases, ulcer, & bowel syndrome. Moreover, capsule endoscopes are also expected to witness modest growth in the coming years.

North America was the largest regional market for the gastrointestinal endoscopic U.S was the leading market for gastrointestinal endoscopic devices in North America in 2015. North America accounted for more than 30% share of the global gastrointestinal endoscopic devices market. Europe followed North America in terms of demand for gastrointestinal endoscopic devices. However, poor reimbursement policies for imaging procedures and drop in government funding in various nations such as Europe and the U.S. are few factors impeding market growth. Asia Pacific is expected to be the fastest regional market for gastrointestinal endoscopic devices on account of the rising and aging population in China, India, and Australia. In addition, the expansion of health insurance coverage in Asia Pacific is expected to increase access to healthcare, government initiative to lower direct taxes, higher depreciation on medical equipment, income tax exemption coupled with increasing medical tourism in India, Singapore and Thailand which in turn is expected to augment the demand for gastrointestinal endoscopic devices in the near future.

Major market players in this industry are Covidien Ltd., Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Ltd., Fujinon Ltd and Conmed Corporation among others.  The growing geriatric population is yet another reason that will impel growth in the global gastrointestinal endoscopic devices market, making it imperative for players to launch high-end endoscopic devices. Many players in the pharmaceutical sector are aiming at research & development activities in order to introduce potential breakthroughs for the development of improved and more effective gastrointestinal endoscopic devices.